Armstrong Mac sold $484K of PLMR (indirect holdings)

Palomar (NASDAQ: PLMR) reported Q2 earnings call highlights, including crop underwriting contributions and a new AI policy administration platform (PLMR.Farm). Management guided a mid- to upper-30% full-year loss ratio, peaking in Q3. The company repurchased 368,719 shares for about $41M, authorized a $0.45 quarterly dividend, and reported $14.3M favorable prior-year reserve development.

Palomar Holdings reported record adjusted net income on diversification across earthquake, casualty, and crop. Management raised full-year 2026 adjusted net income guidance to $270 million to $280 million and expects loss ratios to trend to the mid-to-upper 30s. Palomar authorized a $0.45 quarterly dividend and cited conservative reserving, with 84% of casualty reserves as IBNR.

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

Palomar Holdings (NASDAQ:PLMR) reported Q2 2026 results. Revenue rose 54.7% year over year to $314.4 million, exceeding analysts’ estimates by 5%, and non-GAAP EPS was $2.36, 6.6% above consensus. The company said gross written premium rose 27% and net premiums earned were $287 million, up 59.5%.

Palomar Holdings, Inc. (PLMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Palomar Holdings, Inc. Reports Second Quarter 2026 Results LA JOLLA, Calif. (August 4, 2026) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $52.6 million , or $1.94 per diluted share, for the second quarter of 2026 compared to

Palomar Holdings (NASDAQ: PLMR) shares rose about 4.1% after JP Morgan analyst Pablo S. Singzon kept an Overweight rating and raised the price target from $150 to $167. The target increase implies about 11.3% upside. Shares later traded around $140.80, up 4% from the prior close.